BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17011983)

  • 1. Unusual complex hyperdiploid karyotypes in myelodysplastic syndromes.
    Stamatoullas A; Callat MP; Marreiros S; Tilly H; Bastard C
    Cancer Genet Cytogenet; 2006 Oct; 170(2):129-32. PubMed ID: 17011983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chromosome abnormalities in myelodysplastic syndrome].
    Fujita K; Mori H; Niikura H; Terada H; Shinohara T
    Rinsho Byori; 1990 Aug; 38(8):911-6. PubMed ID: 2232253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
    Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R
    Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and cytogenetic features of 29 cases of myelodysplastic syndrome associated with del(20q)].
    Qin S; Liu SH; Bo LJ; Liu XP; Li CW; Dai Y; He GS; Shao ZH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):171-2. PubMed ID: 15079804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM; Stass SA; Pierce S; Estey EH
    Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients].
    Dewulf G; Gouin I; Pautas E; Gaussem P; Chaïbi P; Andreux JP; Siguret V
    Ann Biol Clin (Paris); 2004; 62(2):197-202. PubMed ID: 15047472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
    Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytogenetic study of 93 myelodysplastic syndromes].
    Solé F; Woessner S; Florensa L; Pérez-Losada A; Acín P; Besses C; García-Eroles L; Sans-Sabrafen J
    Med Clin (Barc); 1998 Jan; 110(3):94-8. PubMed ID: 9534140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytogenetic findings in patients with primary myelodysplastic syndrome and their prognostic significance. (Analysis of results in 65 patients)].
    Indrák K; Jarosová M; Sulovská I; Scudla V; Hubácek J; Sousková I; Bĕhal K; Svobodová M
    Vnitr Lek; 1994 Sep; 40(9):577-85. PubMed ID: 7975361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.
    Malcovati L; Porta MG; Pascutto C; Invernizzi R; Boni M; Travaglino E; Passamonti F; Arcaini L; Maffioli M; Bernasconi P; Lazzarino M; Cazzola M
    J Clin Oncol; 2005 Oct; 23(30):7594-603. PubMed ID: 16186598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
    Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
    Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prognostic value of quantitative chromosomal abnormality in myelodysplastic syndromes].
    Wang HQ; Shao ZH; Cao YR; Shi J; Liu H; Bai J; Tu MF; Xing LM; Cui ZZ; Liu SH; Sun J; Jia HR; Yang TY
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):28-31. PubMed ID: 16732936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome.
    Yamamoto K; Okamura A; Katayama Y; Shimoyama M; Matsui T
    Leuk Res; 2009 Mar; 33(3):377-83. PubMed ID: 18829109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping.
    Martínez-Ramírez A; Urioste M; Alvarez S; Vizmanos JL; Calasanz MJ; Cigudosa JC; Benítez J
    Cancer Genet Cytogenet; 2004 Aug; 153(1):39-47. PubMed ID: 15325092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
    Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ
    Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.